NCT00031746View on ClinicalTrials.gov

Soy Protein Supplement in Preventing Prostate Cancer in Patients With Elevated Prostate-Specific Antigen Levels

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

February 29, 2000

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions
Prostate Cancer
Interventions
DIETARY_SUPPLEMENT

soy protein isolate

25 mg daily

DIETARY_SUPPLEMENT

casein proteins

25 mg daily

Trial Locations (5)

13057

CCOP - Hematology-Oncology Associates of Central New York, Syracuse

13215

Community General Hospital of Greater Syracuse, Syracuse

20307-5001

Walter Reed Army Medical Center, Washington D.C.

27157-1096

Wake Forest University Comprehensive Cancer Center, Winston-Salem

43210-1240

Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University, Columbus

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT00031746 - Soy Protein Supplement in Preventing Prostate Cancer in Patients With Elevated Prostate-Specific Antigen Levels | Biotech Hunter | Biotech Hunter